CompletedNCT00473642
Reduced Fluence Photodynamic Therapy (PDT) With Visudyne in Combination With Lucentis for Age-Related Macular Degeneration
PHASE4 · 31 planned enrolment
- Countries listed
- 1
- Registry update
- November 6, 2020
immortal.lifeTrial registrations containing the exact intervention label Verteporfin.
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →PHASE4 · 31 planned enrolment
Phase not reported · 0 planned enrolment